BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15821753)

  • 1. Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling.
    Correa F; Mestre L; Docagne F; Guaza C
    Br J Pharmacol; 2005 Jun; 145(4):441-8. PubMed ID: 15821753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK1 dependent and independent ERK activation regulates IL-10 and IL-12 production in bone marrow derived macrophages.
    Bouhamdan M; Bauerfeld C; Talreja J; Beuret L; Charron J; Samavati L
    Cell Signal; 2015 Oct; 27(10):2068-76. PubMed ID: 26208884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-caryophyllene is a dietary cannabinoid.
    Gertsch J; Leonti M; Raduner S; Racz I; Chen JZ; Xie XQ; Altmann KH; Karsak M; Zimmer A
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9099-104. PubMed ID: 18574142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.
    Lombard C; Nagarkatti M; Nagarkatti P
    Clin Immunol; 2007 Mar; 122(3):259-70. PubMed ID: 17185040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator regulates macrophage activation and innate immunity.
    Mantuano E; Azmoon P; Brifault C; Banki MA; Gilder AS; Campana WM; Gonias SL
    Blood; 2017 Sep; 130(11):1364-1374. PubMed ID: 28684538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10.
    Robinson RH; Meissler JJ; Fan X; Yu D; Adler MW; Eisenstein TK
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):318-32. PubMed ID: 25980325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune and glial cell alterations in the rat brain after repeated exposure to the synthetic cannabinoid JWH-018.
    Pintori N; Mostallino R; Spano E; Orrù V; Piras MG; Castelli MP; De Luca MA
    J Neuroimmunol; 2024 Apr; 389():578325. PubMed ID: 38432046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two.
    Bisicchia E; Chiurchiù V; Viscomi MT; Latini L; Fezza F; Battistini L; Maccarrone M; Molinari M
    Cell Mol Life Sci; 2013 Jun; 70(12):2191-204. PubMed ID: 23296125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Analysis Reveals a Subset of High IL-12p40-Secreting Dendritic Cells within Mouse Bone Marrow-Derived Macrophages Differentiated with M-CSF.
    Bridges K; Pizzurro GA; Khunte M; Chen M; Salvador Rocha E; Alexander AF; Bass V; Kellman LN; Baskaran J; Miller-Jensen K
    J Immunol; 2024 Apr; 212(8):1357-1365. PubMed ID: 38416039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.
    Persidsky Y; Fan S; Dykstra H; Reichenbach NL; Rom S; Ramirez SH
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):302-8. PubMed ID: 25666933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory actions of
    Folle AM; Lagos Magallanes S; Fló M; Alvez-Rosado R; Carrión F; Vallejo C; Watson D; Julve J; González-Sapienza G; Pristch O; González-Techera A; Ferreira AM
    Front Cell Infect Microbiol; 2024; 14():1362765. PubMed ID: 38562963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prebiotics Plus Probiotics May Favorably Impact on Gut Permeability, Endocannabinoid Receptors, and Inflammatory Biomarkers in Patients with Coronary Artery Diseases: A Clinical Trial.
    Liu M; Tandorost A; Moludi J; Dey P
    Food Sci Nutr; 2024 Feb; 12(2):1207-1217. PubMed ID: 38370067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological blockade of cannabinoid receptor 2 signaling does not affect LPS/IFN-γ-induced microglial activation.
    Olabiyi BF; Schmoele AC; Beins EC; Zimmer A
    Sci Rep; 2023 Jul; 13(1):11105. PubMed ID: 37429837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective CB
    Hall S; Faridi S; Trivedi P; Sultana S; Ray B; Myers T; Euodia I; Vlatten D; Castonguay M; Zhou J; Kelly M; Lehmann C
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid System in the Neuroendocrine Response to Lipopolysaccharide-induced Immune Challenge.
    De Laurentiis A; Correa F; Fernandez Solari J
    J Endocr Soc; 2022 Oct; 6(10):bvac120. PubMed ID: 36042978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies.
    García-Gutiérrez MS; Navarrete F; Gasparyan A; Navarro D; Morcuende Á; Femenía T; Manzanares J
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis.
    Khan H; Ghori FK; Ghani U; Javed A; Zahid S
    Mol Biol Rep; 2022 Jun; 49(6):5117-5131. PubMed ID: 35182322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol modulation of oxidative stress and signalling.
    Pereira SR; Hackett B; O'Driscoll DN; Sun MC; Downer EJ
    Neuronal Signal; 2021 Sep; 5(3):NS20200080. PubMed ID: 34497718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist.
    Hashiesh HM; Sharma C; Goyal SN; Jha NK; Ojha S
    Front Pharmacol; 2021; 12():702675. PubMed ID: 34393784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and Autoimmunity: Possible Mechanisms of Action.
    Giorgi V; Marotto D; Batticciotto A; Atzeni F; Bongiovanni S; Sarzi-Puttini P
    Immunotargets Ther; 2021; 10():261-271. PubMed ID: 34322454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.